Suzuken Reshapes Pharmaceutical Logistics with Intra-Group Split and New Subsidiary

Suzuken Co ( (JP:9987) ) has provided an announcement.

Suzuken will restructure its intra-group logistics operations by carving out S.D. Collabo’s manufacturer logistics services into a new wholly owned subsidiary, Collabo CREATE Co., Ltd., while leaving S.D. Collabo focused on its specialty drug contract distribution business. The move aims to deepen specialization, strengthen logistics frameworks for pharmaceutical clients, and support further growth in a competitive market.

In parallel, Suzuken will absorb manufacturer logistics-related assets from S.D. Logi to the parent company to improve overall efficiency and talent development across the group’s logistics platform. The reorganization consolidates nearly two decades of logistics know-how into more clearly defined entities, positioning the group to better address social challenges such as cost control and stable supply in pharmaceutical distribution.

The most recent analyst rating on (JP:9987) stock is a Hold with a Yen7029.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.

More about Suzuken Co

Suzuken Co. is a Japan-based pharmaceutical wholesaler with a strong focus on pharmaceutical logistics and distribution. Through subsidiaries such as S.D. Collabo and S.D. Logi, the group provides contract logistics services for drug manufacturers and operates a specialty drug contract distribution business, particularly for high-cost and advanced therapies.

Average Trading Volume: 166,845

Technical Sentiment Signal: Buy

Current Market Cap: Yen371.8B

Learn more about 9987 stock on TipRanks’ Stock Analysis page.